Reslizumab T12706
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Reslizumab is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma.
CAS nr:
241473-69-8
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Immunology/Inflammation
Target:
IL Receptor
